Furthermore, miR-184 and miR-197 were up-regulated in LADC tumor tissue patients, who harbor EGFR mutations with brain metastasis, indicating these miRNAs as novel biomarkers differentiating the risk of brain metastasis [185]. This evidence concerns the gene EGFR and neoplasm.